Clinical Trial Update: Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating decitabine followed by clofarabine, idarubicin, and cytarabine in acute leukemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)
• Decitabine (Decitabine)
• Idarubicin (idarubicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-10